|
CHMP2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63913327355658E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.18499679355477E-11 |
| Normal-vs-Stage2 |
4.601200E-03 |
| Normal-vs-Stage3 |
8.1588003020272E-10 |
| Normal-vs-Stage4 |
1.83589999869227E-08 |
| Stage1-vs-Stage2 |
8.680400E-01 |
| Stage1-vs-Stage3 |
3.423400E-01 |
| Stage1-vs-Stage4 |
3.974300E-02 |
| Stage2-vs-Stage3 |
7.798000E-01 |
| Stage2-vs-Stage4 |
2.463400E-01 |
| Stage3-vs-Stage4 |
1.929030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77491354946824E-12 |
| Normal-vs-AfricanAmerican |
4.94699999997739E-06 |
| Normal-vs-Asian |
3.072200E-01 |
| Caucasian-vs-AfricanAmerican |
1.273770E-01 |
| Caucasian-vs-Asian |
6.153400E-01 |
| AfricanAmerican-vs-Asian |
3.530000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44080303243754E-11 |
| Normal-vs-Female |
1.38888900380607E-13 |
| Male-vs-Female |
1.706780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.039500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.61229918305139E-11 |
| Normal-vs-Age(61-80Yrs) |
8.2261975009601E-12 |
| Normal-vs-Age(81-100Yrs) |
5.203800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.017400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.221400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.676000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.938600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.692600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.946400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.987550E-02 |
| Normal-vs-Grade 2 |
3.1368999620085E-09 |
| Normal-vs-Grade 3 |
3.33844063504785E-13 |
| Normal-vs-Grade 4 |
6.81489999987406E-07 |
| Grade 1-vs-Grade 2 |
8.161400E-01 |
| Grade 1-vs-Grade 3 |
7.644800E-01 |
| Grade 1-vs-Grade 4 |
6.385200E-01 |
| Grade 2-vs-Grade 3 |
1.317040E-01 |
| Grade 2-vs-Grade 4 |
1.158580E-01 |
| Grade 3-vs-Grade 4 |
6.093800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.86672899360474E-12 |
| Normal-vs-ccB subtype |
8.4865000000045E-05 |
| ccA subtype-vs-ccB subtype |
2.263800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84339995992866E-09 |
| Normal-vs-N1 |
7.030100E-02 |
| N0-vs-N1 |
8.341200E-01 |
|
|
